Sangamo Therapeutics (SGMOQ) Free Cash Flow Growth (1y) (2011 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Free Cash Flow Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn | 40.14% |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn | 11.55% |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -235.00% |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn | -14.39% |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn | 17,755.56% |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | -656.18% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -656.18% |
| Sep 30, 2025 | -341.34% |
| Jun 30, 2025 | 32.89% |
| Mar 31, 2025 | 46.29% |
| Dec 31, 2024 | 93.93% |
| Sep 30, 2024 | 123.59% |
| Jun 30, 2024 | 59.46% |
| Mar 31, 2024 | 35.79% |
| Dec 31, 2023 | 17.53% |
| Sep 30, 2023 | 13.78% |
| Jun 30, 2023 | -11.48% |
| Mar 31, 2023 | -23.76% |
| Dec 31, 2022 | -16.11% |
| Sep 30, 2022 | 10.21% |
| Jun 30, 2022 | 0.67% |
| Mar 31, 2022 | 19.20% |
| Dec 31, 2021 | -569.06% |
| Sep 30, 2021 | -322.41% |
| Jun 30, 2021 | -138.09% |
| Mar 31, 2021 | -237.52% |